NCT05065866 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05065866
Title	Duvelisib in Combination With CC-486 in Lymphoid Malignancy
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	H. Lee Moffitt Cancer Center and Research Institute
Indications	diffuse large B-cell lymphoma aggressive NK-cell leukemia mantle cell lymphoma lymphoma adult T-cell leukemia/lymphoma prolymphocytic leukemia B-cell lymphoma primary mediastinal B-cell lymphoma
Therapies	Azacitidine + Duvelisib
Age Groups:	adult \| senior
Covered Countries	USA

NCT05065866
Clinical Trial Detail